Buy Full Version
"Gastrointestinal Stents Market"

Let us help you !

Invalid Email.

Please Select Country.

Invalid contact no.

Special Symbols Not Allowed.

Invalid Security Code.

Thank You For Your Interest.

We've Successfully Got Your Message,

Our Executive will get back to you Shortly.

Gastrointestinal Stents Market by Product (Esophageal Stents, Duodenal Stents, Colonic Stents, and Biliary or Pancreatic Stents); by Material (Metal, Plastic, and Biodegradable or Drug Eluting Stents); by Indication (Gastrointestinal Obstructions, Colorectal Cancer, and Inflammatory Bowel Disease); and End User (Hospitals and Ambulatory Surgical Centers) - Global Opportunities and Industry Forecasts, 2019-2026

Medical Devices & Supplies	LI_183534	Pages: NA	Jan 2020 \| 1319 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

A stent is a tube-like implant that is implanted in the lumen of any blood vessel or a duct in order to keep the passage open. Gastrointestinal stents are employed to open bile ducts, esophagus, small bowel, and colon when they are blocked by large, cancerous tissues. The incorporation of stents improves the patients natural ability to digest food and drinks when they undergo trouble in swallowing, passing stools, or digestion during their cancer treatment.

The major factors that contribute to the growth of the gastrointestinal stents market include increasing prevalence of gastrointestinal diseases, high demand for minimal invasive procedures, technological developments in devices such as bio absorbable gastrointestinal stents, and growth in geriatric population. However, stringent governmental regulations and complications linked with gastrointestinal stents are expected to restrain the market development. Rising demand for newer versions of gastrointestinal stents such as nitinol material-based gastrointestinal stents and improving healthcare infrastructure in emerging countries contribute to significant demand for gastrointestinal stents in the near future.

The global gastrointestinal stents market is segmented on the basis of product, material, indication, end-user, and region. On the basis of product, the market is segmented into esophageal stents, duodenal stents, colonic stents, and biliary or pancreatic stents. According to material of stents the market is divided into metal, plastic, and biodegradable or drug eluting stents. Based on indication, the market is categorized into gastrointestinal obstructions, colorectal cancer, inflammatory bowel disease, and others, which include gastrointestinal bleeding and gastric cardia cancer.

On the basis of end user, the market is segmented into hospitals, ambulatory surgical centers, and others, which include clinics and academic & research centers. Geographically, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players that operate in this market include Boston Scientific Corporation, Medtronic Plc., CONMED Corporation, Becton, Dickinson and Company, ELLA - CS, s.r.o., Taewoong Medical Co., Ltd., BVM Medical Limited, Hobbs Medical, Inc., Merit Medical Systems, Inc., and Cook Group Incorporated.

Key Benefits

The study provides an in-depth analysis of the global gastrointestinal stents market with current trends and future estimations to elucidate imminent investment pockets.
The report provides information about the current and upcoming trends in the global gastrointestinal stents market from 2016 to 2023, which helps determine prevailing opportunities.
Comprehensive analysis of factors that drive and restrict the growth of the global gastrointestinal stents market has been provided.
Identification of factors that are instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale have been provided.
Key market players within the market have been profiled in this report and their strategies thoroughly analyzed, which help understand the competitive outlook of the global gastrointestinal stents market.

Gastrointestinal Stents Market Key Segments:

By Product

Esophageal Stents
Duodenal Stents
Colonic Stents
Biliary or Pancreatic Stents

By Material

Metal Stents
Plastic Stents
Biodegradable or Drug Eluting Stents

By Indication

Gastrointestinal Obstructions
Colorectal Cancer
Inflammatory Bowel Disease
Others

By End User

Hospitals
Ambulatory Surgical Centers
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

CHAPTER 4 GASTROINTESTINAL STENTS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. ESOPHAGEAL STENTS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. DUODENAL STENTS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. COLONIC STENTS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. BILIARY OR PANCREATIC STENTS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

CHAPTER 5 GASTROINTESTINAL STENTS MARKET, BY MATERIAL

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. METAL

5.2.1. Market size and forecast

5.3. PLASTIC

5.3.1. Market size and forecast

5.4. BIODEGRADABLE OR DRUG ELUTING STENTS

5.4.1. Market size and forecast

CHAPTER 6 GASTROINTESTINAL STENTS MARKET, BY INDICATION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. GASTROINTESTINAL OBSTRUCTIONS

6.2.1. Market size and forecast

6.3. COLORECTAL CANCER

6.3.1. Market size and forecast

6.4. INFLAMMATORY BOWEL DISEASE

6.4.1. Market size and forecast

6.5. OTHERS

6.5.1. Market size and forecast

CHAPTER 7 GASTROINTESTINAL STENTS MARKET, BY END USER

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. HOSPITALS

7.2.1. Market size and forecast

7.3. AMBULATORY SURGICAL CENTERS

7.3.1. Market size and forecast

7.4. OTHERS

7.4.1. Market size and forecast

CHAPTER 8 GASTROINTESTINAL STENTS MARKET, BY REGION

8.1. OVERVIEW
8.2. NORTH AMERICA

8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast

8.2.3.1. U.S. market size and forecast
8.2.3.2. Canada market size and forecast
8.2.3.3. Mexico market size and forecast

8.2.4. North America Gastrointestinal Stents Market by Product
8.2.5. North America Gastrointestinal Stents Market by Material
8.2.6. North America Gastrointestinal Stents Market by Indication
8.2.7. North America Gastrointestinal Stents Market by End User

8.3. EUROPE

8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast

8.3.3.1. Germany market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. UK market size and forecast
8.3.3.4. Italy market size and forecast
8.3.3.5. Spain market size and forecast
8.3.3.6. Rest of Europe market size and forecast

8.3.4. Europe Gastrointestinal Stents Market by Product
8.3.5. Europe Gastrointestinal Stents Market by Material
8.3.6. Europe Gastrointestinal Stents Market by Indication
8.3.7. Europe Gastrointestinal Stents Market by End User

8.4. ASIA-PACIFIC

8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast

8.4.3.1. Japan market size and forecast
8.4.3.2. China market size and forecast
8.4.3.3. Australia market size and forecast
8.4.3.4. India market size and forecast
8.4.3.5. South Korea market size and forecast
8.4.3.6. Rest of Asia-Pacific market size and forecast

8.4.4. Asia-Pacific Gastrointestinal Stents Market by Product
8.4.5. Asia-Pacific Gastrointestinal Stents Market by Material
8.4.6. Asia-Pacific Gastrointestinal Stents Market by Indication
8.4.7. Asia-Pacific Gastrointestinal Stents Market by End User

8.5. LAMEA

8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast

8.5.3.1. Brazil market size and forecast
8.5.3.2. Saudi Arabia market size and forecast
8.5.3.3. South Africa market size and forecast
8.5.3.4. Rest of LAMEA market size and forecast

8.5.4. LAMEA Gastrointestinal Stents Market by Product
8.5.5. LAMEA Gastrointestinal Stents Market by Material
8.5.6. LAMEA Gastrointestinal Stents Market by Indication
8.5.7. LAMEA Gastrointestinal Stents Market by End User

CHAPTER 9 COMPANY PROFILES

9.1. BOSTON SCIENTIFIC CORPORATION

9.1.1. Operating business segments
9.1.2. Business performance
9.1.3. Key strategic moves and developments

9.2. MEDTRONIC PLC.

9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments

9.3. CONMED CORPORATION

9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments

9.4. BECTON, DICKINSON AND COMPANY

9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments

9.5. ELLA - CS, S.R.O.

9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments

9.6. TAEWOONG MEDICAL CO., LTD.

9.6.1. Operating business segments
9.6.2. Business performance
9.6.3. Key strategic moves and developments

9.7. BVM MEDICAL LIMITED

9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments

9.8. HOBBS MEDICAL, INC.

9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments

9.9. MERIT MEDICAL SYSTEMS, INC.

9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments

9.10. COOK GROUP INCORPORATED

9.10.1. Operating business segments
9.10.2. Business performance
9.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Online Only ~~$3,456~~ $3,041 Data Pack/Excel ~~$3,840~~ $3,379 Single User License ~~$5,370~~ $4,726 Five User License ~~$6,450~~ $5,676 Enterprise User License ~~$8,995~~ $7,916

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com